Esketamine, a form of ketamine taken as a nasal spray, has been approved for the treatment for moderate to severe treatment-resistant depression in Scotland but intravenous ketamine has not, though it ...

A nasal spray for treatment-resistant depression has delivered strong clinical results and rekindled investor hopes.

Research on synthetic psychedelics progresses, and there's hope to prove psilocybin safe and effective in intractable ...

Due in part to recent reports about Matthew Perry and Elon Musk, ketamine seems to be taking up more and more space in the conversation about substance abuse. But despite its recent spike in ...

Positive data on depression treatment based on a drug related to the psychedelic DMT is breathing life into shares of ...

Atai Life Sciences is making incremental progress towards opening door for a first psychedelic treatment for depression. Read ...

Psychedelics devotees are racing biotech entrepreneurs to turn 5-MeO-DMT, one of the world’s most powerful drugs, into a pharmaceutical.

Today’s health headlines: ketamine nasal sprays offer a new option for people with treatment-resistant depression. Plus, how ...

The Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in a Complete Response Letter (CRL) for etripamil nasal spray (Cardamyst ™ ), an investigational ...

BPL-003 showed “robust” efficacy data in treatment-resistant depression, according to analysts from Jefferies, who noted that ...

MomMed and Cleanote Partner to Launch Family-Friendly Saline Nasal Spray The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties.

Ketamine has been used for decades as an anaesthetic drug, but in the past few years, more and more psychiatrists have been using it for hard-to-treat depression ...